Drugs / Levulan® Kerastick®
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1/2 | NCT03110159 | Aug 2017 → Feb 2024 | actinic keratosis, hyperpigmentation of the skin, skin carcinoma | Medical Dermatology Specialists | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Levulan Kerastick | ClinicalTrials.gov intervention name — accepted as the source's own label NCT03110159 ↗ |
| Route | Topical | “Levulan® Kerastick® for Topical Solution will be applied to a designated area” NCT03110159 ↗ |